Concordia Pharmaceuticals Inc.
$255.0K 3 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Aidoc Medical Ltd
Aidoc Medical Ltd reported $254,637.50 across General Payments, Research, and Ownership to 87 physicians and teaching hospitals across 90 transactions.
- $254.6K Above-median payer
- All-tracks total
- 90 Below-median volume
- Transactions
- 87 Below-median reach
- Recipients
- +$60.1K
- General Payments vs PY2023
Aidoc Medical Ltd reported $254,637.50 across all CMS Open Payments tracks (General + Research + Ownership) to 87 physicians and teaching hospitals in Program Year 2024 - ranking #934 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $83,517.50, averaging $2.9K per recipient.
How Aidoc Medical Ltd's $254.6K all-tracks total breaks down
Aidoc Medical Ltd's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer aidoc-medical-ltd Aidoc Medical Ltd
$254.6K · #934/1,925 · 0.0% industry · PY2024
- TOT $254.6K
- RANK #934
- SHARE 0.0%
- TXN 90
- RCP 87
- CAT 2
- GEN $83.5K
- ΔGEN +$60.1K
- TOP1 47.5%
- PY 2024
Volume peers
Nearest volume peer: Concordia Pharmaceuticals Inc. ($255.0K)
Aidoc Medical Ltd sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Aidoc Medical Ltd's CMS-reported General Payments increased by $60.1K (+256.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AIDOC MEDICAL LTDPY2023: AIDOC MEDICAL LTDPY2024: Aidoc Medical Ltd. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $23,461.68
- PY2024
- $83,517.50
What the Data Shows for Aidoc Medical Ltd
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Aidoc Medical Ltd, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $80.4K across 43 transactions, 96.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Aidoc Medical Ltd's 2-category general-payment breakdown at $80.4K, 96.3% of the reported total.
How Aidoc Medical Ltd divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $80.4K | 43 | 96.3% |
| Food and Beverage | $3.1K | 44 | 3.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $62,302.50 (74.6%) of $83,517.50 in this company's General Payments records across 57 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Aidoc Medical Ltd
The five named recipients with the highest reported General Payments from this company
- 1
Miriam Hulkower
$39,632.50 across 11 reported transactions
- 2
Scott Williams
$8,750.00 across 7 reported transactions
- 3
Naiem Nassiri
$4,800.00 across 3 reported transactions
- 4
Avishkar Sharma
$4,570.00 across 3 reported transactions
- 5
Michael Shapiro
$4,550.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Aidoc Medical Ltd's spend rank (#934 of 1,925, top 49% by spend) and concentration rank (#640 of 1,838, top 35% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Atrium Medical Corporation : $13.1K total payments, HHI 2591
- DeGen Medical, Inc. : $324.9K total payments, HHI 2579
- Nutech Spine, Inc. : $22.0K total payments, HHI 2564
- Next Science LLC : $546.4K total payments, HHI 2560
- FEMSelect Inc. : $65.2K total payments, HHI 2552
- Skye Orthobiologics LLC : $7.2M total payments, HHI 2533
- Aidoc Medical Ltd (this company) : $83.5K total payments, HHI 2529
- Boehringer Ingelheim RCV GmbH & Co KG : $63.7K total payments, HHI 2525
- Oxford Performance Materials, Inc. : $21.8K total payments, HHI 2520
- Avirmax Biopharma, Inc : $631.49 total payments, HHI 2519
- IBSA Institut Biochimique SA : $50.0K total payments, HHI 2512
- Ignite Orthomotion LLC : $27.3K total payments, HHI 2504
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Aidoc Medical Ltd's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Aidoc Medical Ltd.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Aidoc Medical Ltd.
Showing 6 of 1,924 companies with CMS-reported payment data.
Radical Catheter Technologies, Inc.
$255.2K 18 recipients
Compare payment profiles
Qapel Medical Inc
$256.6K 768 recipients
Compare payment profiles
Essential Medical, Inc.
$252.4K 0 recipients
Compare payment profiles
FUJIFILM Sonosite, Inc.
$257.0K 246 recipients
Compare payment profiles
Clinigen, Inc.
$251.9K 2 recipients
Compare payment profiles
Put this to use
Aidoc Medical Ltd ranks #934 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Aidoc Medical Ltd. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.